In the News

Four of America's biggest healthcare companies are close to a $26 billion settlement for their role making and distributing highly addictive opioid medications.
But critics in Congress say corporate tax breaks could slash the value of the deal by more than $4 billion.
"If they get away with it, that means less money going into the treasury, less money for programs that would help deal with the fallout for the opioid crisis," said Rep. Jimmy Gomez (D-CA).